<DOC>
	<DOCNO>NCT02306213</DOCNO>
	<brief_summary>Recent study show increased incidence renal replacement therapy use Hydroxyethylstarchs ( HES ) patient admit intensive care unit . However , study show detrimental effect HES conduct mostly non-surgical subject . There study analyze effect HES renal function cardiac surgery , population already risk renal dysfunction .</brief_summary>
	<brief_title>Effect Hydroxyethylstarch 6 % 130/0.4 Administration Renal Function After Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>All patient undergo cardiac surgery Heart transplantation Ventricular assist device Patients require extracorporeal life support cardiac surgery Patients revise bleed and/or tamponnade present hemodynamic instability Patients administered volume therapy completely available Subjects require renal replacement therapy surgery Trauma patient put cardiopulmonary bypass Patients die intraoperatively soon arrival intensive care unit postoperative creatinine measurement available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>